Gelteq Limited Ordinary Shares (GELS) Stock Analysis & Investment Frameworks
Gelteq Limited Ordinary Shares (GELS) stock analysis on Invetso. Review Gelteq Limited Ordinary Shares’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Gelteq Limited Ordinary Shares Company Overview
- Exchange: NASDAQ Global Select
- Sector: Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Country: AU
Gelteq Limited Ordinary Shares Key Financial Metrics
- Market Cap: $4.23M
- Revenue: $115934.94
- ROE: -36.08%
- ROIC: -25.59%
- Dividend Yield: N/A
About Gelteq Limited Ordinary Shares
Gelteq Limited, established in 2017 and based in Caulfield, Australia, specializes in creating and commercializing advanced gel-based delivery methods for both human and animal use. The company offers customizable, white-label gel formulations that can be applied to a broad array of goods, such as prescribed pharmaceuticals, non-prescription remedies, nutritional supplements (including sports-related products), and veterinary care items.
Gelteq Limited Ordinary Shares Investment Frameworks
Invetso analyzes Gelteq Limited Ordinary Shares (GELS) across the following frameworks:
- Gelteq Limited Ordinary Shares 10Y Growth Potential
- Gelteq Limited Ordinary Shares Scenario Analysis
- Gelteq Limited Ordinary Shares Risks & Opportunities
- Gelteq Limited Ordinary Shares Economic Moat
- Gelteq Limited Ordinary Shares Business Model
- Gelteq Limited Ordinary Shares Management
- Gelteq Limited Ordinary Shares SWOT Analysis
- Gelteq Limited Ordinary Shares Porter's 5 Forces
- Gelteq Limited Ordinary Shares PESTLE Analysis
- Gelteq Limited Ordinary Shares ESG Analysis